In addition, Dex treatment reversed the increased p-CaMKII levels in Aβ25–35 mice to the control level; p-CaMKII plays an essential role in synaptic plasticity and spatial memory formation in AD (Reese et al., 2011). This evidence concerns the gene CAMK2G and Alzheimer disease.